Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme. (Q39695508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Nichole L Bryant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

G Yancey Gillespie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Richard D Lopez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

James M Markert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gretchen A Cloud

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Catherine P Langford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yun Su

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hilary L Haines

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Catalina Suarez-Cuervo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Lawrence S Lamb

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

10 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

179-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20532954%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-010-0245-2

5 February 2020

exact match

0 references

cites work

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0245-2

MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

21 January 2018

1 reference

12 December 2020

Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma

1 reference

12 December 2020

Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

1 reference

12 December 2020

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

1 reference

12 December 2020

The effect of intravenous interleukin-2 on brain water content

1 reference

12 December 2020

Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12.

1 reference

12 December 2020

Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation

1 reference

12 December 2020

NK cells recognize and kill human glioblastoma cells with stem cell-like properties

1 reference

12 December 2020

Regulation of cutaneous malignancy by gammadelta T cells

1 reference

12 December 2020

In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.

1 reference

12 December 2020

CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.

1 reference

12 December 2020

Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.

1 reference

12 December 2020

Fas-dependent, activation-induced cell death of gammadelta cells.

1 reference

12 December 2020

Antigen-presenting properties of human epidermal cells compared with peripheral blood mononuclear cells

1 reference

12 December 2020

Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma

1 reference

12 December 2020

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

12 December 2020

Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells.

1 reference

12 December 2020

Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease

1 reference

12 December 2020

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes

1 reference

12 December 2020

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

1 reference

12 December 2020

Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gammadeltaT cells isolated from glioblastoma patients

1 reference

12 December 2020

Current and future strategies for the treatment of malignant brain tumors.

1 reference

12 December 2020

Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.

1 reference

12 December 2020

Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system

1 reference

12 December 2020

Human Alloreactive CTL Interactions with Gliomas and with Those Having Upregulated HLA Expression from Exogenous IFN-γ or IFN-γ Gene Modification

1 reference

12 December 2020

V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes

1 reference

12 December 2020

Systemic T cell adoptive immunotherapy of malignant gliomas.

1 reference

12 December 2020

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

12 December 2020

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

12 December 2020

Distinct pattern of HSP72 and monomeric laminin receptor expression in human lung cancers infiltrated by γ/δ T lymphocytes

1 reference

12 December 2020

gammadelta T-cell receptors: functional correlations

1 reference

12 December 2020

CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunothera

1 reference

12 December 2020

Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients.

1 reference

12 December 2020

Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma.

1 reference

12 December 2020

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

1 reference

12 December 2020